Medtech Talk

CEO John Pedersen Explains Why Urology – and Augmenix – Are Enjoying Such an “Interesting Time”

06.13.2018 - By HealthegyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this Medtech Talk Podcast, CEO John Pedersen explains why he chose to help Augmenix roll out its SPACEOAR implant, a hydrogel that's inserted between a patient's prostate and rectum to save healthy tissue from radiation exposure. In this talk, Pedersen discusses the rise of urology - which includes the recent acquisitions of Neotract and NxThera. He also updates listeners on Augmenix's efforts to secure reimbursement. Finally, the former Boston Scientific exec offers advice to anyone worki...

More episodes from Medtech Talk